We previously reported that treatment of pancreatic cancer heterotopic allografts with anti-BAG3 antibody down-modulated CAF activation and impaired the desmoplastic structure in pancreatic cancer stroma [13]. Here, BAG3 is linked to pancreatic neoplasm.